Arginine vasopressin gene expression changes within the nucleus accumbens during environment elicited cocaine-conditioned response in rats

Neuropharmacology

Volumn 58, Issue 1, 2010, Pages 88-101

  Rodriguez Borrero E ^a   Rivera Escalera, F ^a   Candelas, F ^a   Montalvo, J ^a   Munoz Miranda W J ^a   Walker, J R ^b   Maldonado Vlaar, C S ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b Novartis Genome Institute   (United States)

Author keywords

Accumbens; Arginine vasopressin; Cocaine; Gene; Microarrays; Rat

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA PROTEIN; APYRASE; ARGIPRESSIN; ARGIPRESSIN[4-9]; BRANCHED CHAIN AMINO ACID AMINOTRANSFERASE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL; CALRETICULIN; CATHEPSIN L; COCAINE; COLD SHOCK PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; GLUTAMATE RECEPTOR; INWARDLY RECTIFYING POTASSIUM CHANNEL; MICROTUBULE ASSOCIATED PROTEIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PLECKSTRIN; PROTEIN KINASE FYN; PROTEOCHONDROITIN SULFATE; PROTIRELIN; RAB11 PROTEIN; RIBOSOME PROTEIN; SODIUM CHLORIDE; TENASCIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1A RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; COCAINE DEPENDENCE; CONDITIONED REFLEX; CONDITIONING; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HIGH THROUGHPUT SCREENING; IMMUNOLOCALIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

ANIMALS; ARGININE VASOPRESSIN; COCAINE; CONDITIONING, OPERANT; DOPAMINE UPTAKE INHIBITORS; ENVIRONMENT; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGOPEPTIDES; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 71549148037     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.06.040     Document Type: Article

References (56)

1. Ben-Barak Y., Russell J., Whitnall M., Ozato K., and Gainer H. Neurophysin in the hypothalamo-neurohypophysial system. I. Production and characterization of monoclonal antibodies. J. Neurosci. 5 (1985) 81-97
2. Bibb J., Nishi A., O'Callaghan J., Ule J., Lan M., Snyder G., Horiuchi A., Saito T., Hisanaga S., Andrew J., Czernik A., Nairn A., and Greengard P. Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276 (2001) 14490-14497
3. Brown E.E., Robertson G.S., and Fibiger H.C. Evidence for conditional neuronal activation following exposure to a cocaine-paired environment; role of forebrain limbic structures. J. Neurosci. 12 (1992) 4112-4121
4. Brown E.E., and Fibiger H.C. Cocaine-induced conditioned locomotion: absence of associated increases in dopamine release. Neurosci. 48 3 (1992) 621-629
5. Butovsky E., Juknat A., Elbaz J., Shabat-Simon M., Eilam R., Zangen A., Altstein M., and Vogel Z. Chronic exposure to Delta9-tetrahydrocannabinol downregulates oxytocin and oxytocin-associated neurophysin in specific brain areas. Mol Cell Neurosci. 31 4 (2006) 795-804
6. Carlezon Jr. W.J., Thome J., Olson V.G., Lane-Ladd S.B., Brodkin E.S., Hiroi N., Duman R.S., Neve R.L., and Nestler E. Regulation of cocaine reward by CREB. Science 282 (1998) 2272-2275
7. Choi D.C., Furay A.R., Evanson N.K., Ostrander M.M., Ulrich-Lai Y.M., and Herman J.P. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J. Neurosci. 27 (2007) 2025-2034
8. Chui J., Kalant H., and Le D.A. Vasopressin opposes locomotor stimulation by ethanol, cocaine and amphetamine in mice. Eur. J. Pharmacol. 355 (1998) 11-17
9. Daunais J., and McGinty J. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Brain Res. Mol. Brain Res. 35 1-2 (1996) 237-248
10. De Vry J., Donselaar I., and JM van Ree J. Effects of desglycinamide9, (Arg8) vasopressin and vasopressin antiserum on the acquisition of intravenous cocaine self-administration in the rat. Life Sci. 42 26 (1988) 2709-2715
11. Dorsa D., Petracca F., Baskin D., and Cornett L. Localization and characterization of vasopressin-binding sites in the amygdala of the rat brain. J. Neurosci. 4 (1984) 1764-1770
12. Engelmann M., Wotjak C.T., Neumann I., Ludwig M., and Landgraf R. Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory. Neurosci. Biobehav Rev. 20 3 (1996) 341-358
13. Ettenberg A., Le Moal M., Koob G., and Bloom F. Vasopressin potentiation in the performance of a learned appetitive task: reversal by a pressor antagonist analog of vasopressin. Pharmacol. Biochem. Behav. 18 4 (1983) 645-647
14. Ettenberg A., van der Kooy D., Le Moal M., Koob G., and Bloom F. Can aversive properties of (peripherally-injected) vasopressin account for its putative role in memory?. Behav. Brain Res. 7 3 (1983) 331-350
15. Ferger B., and Kuschinsky K. A comparison of different sensory stimuli in producing conditioning apomorphine effects. Behav. Pharmacol. 6 (1995) 40-45
16. Freeman W.M., Nader M.A., Nader S.H., Robertson D.J., Gioia L., Mitchell S.M., Daunais J.B., Porrino L.J., Friedman D.P., and Vrana K.E. Chronic cocaine-mediated changes in non-human primate NA gene expression. J. Neurochem. 77 (2001) 542-549
17. Freeman W.M., Brebner K., Lynch W., Patel K.M., Robertson D.J., Roberts D.C.S., and Vrana K.E. Changes in rat frontal cortex gene expression following chronic cocaine. Mol. Brain. Res. 104 (2002) 11-20
18. Freeman W.M., Patel K.M., Brucklacher R.M., Lull M.E., Erwin M., Morgan D., Roberts D.C., and Vrana K.E. Persistent alterations in mesolimbic gene expression with abstinence from cocaine self-administration. Neuropsychopharmacology 33 8 (2008) 1807-1817
19. Goeders N. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301 (2002) 785-789
20. Goeders N. The HPA axis and cocaine reinforcement. Psychoneuroendocrinology 27 1-2 (2002) 13-33
21. Hyman S.E., and Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat. Rev. Neurosci. 2 (2001) 695-703
22. Insel T., Wang Z., and Ferris C. Patterns of brain vasopressin receptor distribution associated with social organization in microtine rodents. J. Neurosci. 14 (1994) 5381-5392
23. Jackson D., Burns R., Trksak G., Simeone B., DeLeon K., Connor D., Harrison R.J., and Melloni R. Anterior hypothalamic vasopressin modulates the aggression-stimulating effects of adolescent cocaine exposure in Syrian hamsters. Neuroscience 133 3 (2005) 635-646
24. Kampman K.M., Pettinati H.M., Volpicelli J.R., Oslin D.M., Lipkin C., Sparkman T., and O'Brien C.P. Cocaine dependence severity predicts outcome in outpatient detoxification from cocaine and alcohol. Am. J. Addict. 13 1 (2004) 74-82
25. Kim S.J., Young L.J., Gonen D., Veenstra-VanderWeele J., Courchesne R., Courchesne E., Lord C., Leventhal B.L., Cook Jr. E.H., and Insel T.R. Transmission disequilibrium testing of arginine vasopressin receptor 1A (AVPR1A) polymorphisms in autism. Mol. Psychiatry 7 5 (2002) 503-507
26. Kruszynski M., Lammek B., Manning M., Seto J., Haldar J., and Sawyer W.H. Two highly potent antagonist of the vasopressor response to Arginine Vasopressin. J. Med. Chem. 23 (1980) 364-368
27. Landgraf R., Kessler M.S., Bunck M., Murgatroyd C., Spengler D., Zimbelmann M., Nussbaumer M., Czibere L., Turck C.W., Singewald N., Rujescu D., and Frank E. Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glycoxalase-I. Neurosci. Biobehavior Rev. 31 1 (2007) 89-102
28. Lim M.M., Murphy A.Z., and Young L.J. Ventral striatopallidal oxytocin and vasopressin V1a receptors in the monogamous prairie vole (Microtus ochrogaster). J. Comp. Neurol. 468 4 (2004) 555-570
29. Martin-Iverson M.T., and McManus D.J. Stimulant-conditioned locomotion is not affected by blockade of D1 and/or D2 dopamine receptors during conditioning. Brain Res. 521 (1990) 175-184
30. Miller M.A., DeVries G.J., al-Shamma H.A., and Dorsa D.M. Decline of vasopressin immunoreactivity and mRNA levels in the bed nucleus of the stria terminalis following castration. J. Neurosci. 12 (1992) 2881-2887
31. Mohr E., and Richter D. Subcellular vasopressin mRNA trafficking and local translation in dendrites. J. Neuroendocrinol. 16 4 (2004) 333-339
32. Nestler E.J. Molecular basis of long term plasticity underlying addiction. Nat. Rev. Neurosci. 2 (2001) 119-128
33. Nestler E.J. The neurobiology of cocaine addiction. Sci. Pract. Perspect. 3 1 (2005) 4-10 (Review)
34. Nestler E.J. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos. Trans. R Soc. Lond B Biol. Sci. 363 1507 (2008) 3245-3255
35. Nestler E., Barrot M., and Self D. FosB: a sustained molecular switch for addiction. PNAS 98 (2001) 11042-11046
36. Paban V., Alescio-Lautier B., Devigne C., and Soumireu-Mourat B. The behavioral effect of vasopressin in the ventral hippocampus is antagonized by an oxytocin receptor antagonist. Eur. J. Pharmacol. 361 2-3 (1998) 165-173
37. Paban V., Alescio-Lautier B., Devigne C., and Soumireu-Mourat B. Fos protein expression induced by intracerebroventricular injection of vasopressin in unconditioned and conditioned mice. Brain Res. 17 (1999) 115-131
38. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1998), Academic Press, San Diego
39. Pitkow L., Sharer C., Ren J., Insel T., Terwilliger E., and Young L. Facilitation of affiliation and pair-bond formation by vasopressin receptor gene transfer into the ventral forebrain of a monogamous vole. J. Neurosci. 21 18 (2001) 7392-7396
40. Pulipparacharuvil S., Renthal W., Hale C.F., Taniguchi M., Xiao G., Kumar A., Russo S.J., Sikder D., Dewey C.M., Davis M.M., Greengard P., Nairn A.C., Nestler E.J., and Cowan C.W. Cocaine regulates MEF2 to control synaptic and behavioral plasticity. Neuron 59 4 (2008) 621-633
41. Ramos-Ortolaza D.L., Negron A., Cruz D., Falcon E., Iturbe M.C., Hernandez-Cajigas M., and Maldonado-Vlaar C.S. Intra-accumbens injections of Neurotensin receptors antagonist SR48692 enhanced cocaine self-administration intake in rats exposed to an environmentally elicited reinstatement paradigm. Brain Res. 1280 (2009) 124-136
42. van Ree J., Burbach-Bloemarts E., and Wallace M. Vasopressin neuropeptides and acquisition of heroin and cocaine self-administration in rats. Life Sci. 42 10 (1988) 1091-1099
43. Rodríguez-Borrero E., Bernardo-Colon A., Burgos-Martir M., Alvarez-Carrillo J.E., Del Campo-Estrada Y., Abella-Ramirez C., and Maldonado-Vlaar C.S. NMDA antagonist AP-5 increase environmentally induced cocaine-conditioned locomotion within the nucleus accumbens. Pharmacol. Biochem. Behav. 85 1 (2006) 178-184
44. Sarnyai Z., Szabo G., Kovacs G., and Telegdy G. Opposite actions of oxytocin and vasopressin in the development of cocaine-induced behavioral sensitization in mice. Pharmacol. Biochem. Behav. 43 2 (1992) 491-494
45. Sato T., Tanaka K., Teramoto T., Ohnishi Y., Hirate K., Irifune M., and Nishikawa T. Facilitative effect of a novel AVP fragment analog, NC-1900, on memory retention and recall in mice. Peptides 25 7 (2004) 1139-1146
46. Thibonnier M., Conarty D., Preston J., Wilkins P., Berti-Mattera L., and Mattera R. Molecular pharmacology of human vasopressin receptors. Adv. Exp. Med. Biol. 449 (1998) 251-276
47. Toda S., McGinty J.F., and Kalivas P.W. Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: a DNA macroarray study. J. Neurochem. 82 (2002) 1290-1299
48. Trembleau A., Morales M., and Bloom F.E. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: light and electron microscopic evidence. J. Neurosci. 14 (1994) 39-53
49. Tropea T.F., Kosofsky B.E., and Rajadhyaksha A.M. Enhanced CREB and DARPP-32 phosphorylation in the nucleus accumbens and CREB, ERK, and GluR1 phosphorylation in the dorsal hippocampus is associated with cocaine-conditioned place preference behavior. J. Neurochem. 106 4 (2008) 1780-1790
50. Verbalis J.G. Whole-body volume regulation and escape from antidiuresis. Am. J. Med. 119 7 Suppl. 1 (2006) S21-S29
51. Whitnall M.H., Key S., Ben-Barak Y., Ozato K., and Gainer H. Neurophysin in the hypothalamo-neurohypophysial system. II. Immunocytochemical studies of the ontogeny of oxytocinergic and vasopressinergic neurons. J. Neurosci. 5 (1985) 98-109
52. Zhang D., Zhang L., Lou D., Nakabeppu Y., Zhang J., and Xu M. The Dopamine D1 receptor is a critical mediator for cocaine-induced gene expression. J. Neurochemistry 82 (2002) 1453-1464
53. Zhang J., Zhang D., and Xu M. Identification of chronic cocaine-induced gene expression through dopamine D1 receptors by using cDNA microarrays. Ann. N.Y. Acad. Sci. 965 (2002) 1-9
54. Zhou Y., Bendor J.T., Yuferov V., Schlussman S.D., Ho A., and Kreek M.J. Amygdalar vasopressin mRNA increases in acute cocaine withdrawal: evidence for opioid receptor modulation. Neuroscience 134 4 (2005) 1391-1397
55. Zhou Y., Leri F., Cummins E., Hoeschele M., and Kreek M.J. Involvement of arginine vasopressin and V1b receptor in heroin withdrawal and heroin seeking precipitated by stress and by heroin. Neuropsychopharmacology 33 2 (2008) 226-236
56. Ziegler D., and Herman J. Neurocircuitry of stress Integration: anatomical pathways regulating the Hypothalamo-Pituitary-Adrenocortical axis of the rat. Integr. Comp. Biol. 42 (2002) 541-551